BioStar Capital

Happy holidays from all of us at BioStar! Wishing you a healthy, bright, and prosperous year ahead. #happyholidays #newyear

Last week, we had a wonderful evening in NYC at the 16th Annual Pulse of the City Gala, hosted by the Cardiovascular Research Foundation. Funds raised at this event allow #CRF to advance cardiovascular innovation, physician training, and education. We are honored to be a part of this community as we continue investing in and advocating for life-changing medical device technologies for cardiovascular disease. #VC #BioStar #Medtech #CRF #Cardiovascular #PULSE2024

Congratulations to MMI - Medical Microinstruments, Inc., one of our portfolio companies, on this incredible award! We are honored to support MMI as they continue to be recognized for transforming the field of microsurgery with their revolutionary robotic technology. Cheers to the entire team!

We are excited to share that our portfolio company MMI - Medical Microinstruments, Inc. has been named among “The Best Inventions of 2024” by TIME magazine! We are proud to partner with #MMI on its journey to redefine the boundaries of microsurgery with its revolutionary robotic system that is transforming patient care in areas such as breast cancer reconstruction, lymphatic surgery, and neurosurgery. Congratulations to Mark Toland, MMI CEO and BioStar Managing Director, and the entire MMI team! Learn more here: https://lnkd.in/eQs2EBit (Image source, TIME Magazine).

#TCT2024 is well underway and taking over Washington, D.C. this year! TCT is the world’s premier educational meeting specializing in interventional cardiovascular medicine. Louis A Cannon, MD, our Founder and Senior Managing Director, served again as a moderator of the TCT Shark Tank Innovation Competition. From a select group of transformative cardiovascular innovations, Symbiosis emerged as the winner for #ValSync, a heart valve replacement that dynamically adapts its form in real-time. Congratulations to #Symbiosis and to all other Shark Tank companies – it was such an innovative and fun group! #VC #BioStar #Medtech #TCT #SharkTank

Our founder, Louis A Cannon, Dr. Juan Granada, President & CEO of the Cardiovascular Research Foundation, and Dr. Partha Sardar, Assistant Professor of Medicine at Columbia University, highlight the essential role of venture capital in supporting innovation that has fueled dramatic improvements in medical care. In this article recently published in the Journal of the American College of Cardiology: Basic to Translational Science, they show how venture capital funding supports and creates innovation which is essential to the future of healthcare. As venture capitalists focused on patients, physicians, and the healthcare system, we are committed to developing transformational technologies in cardiology, orthopedics, and robotics to impact the quality of healthcare. #VC #Medtech #BioStar #Cardiovascular #CRF #TCT

BioStar is in London! Louis A Cannon, MD, FACA, FACC, FACP, FSCAI, BioStar Founder and Senior Managing Director, and Alan Davis, Managing Director, were invited to speak at the Royal Society of Medicine (RSM) on medical innovation and venture capital. We share RSM’s vision of better healthcare for better lives and are honored to contribute this week! #VC #BioStar #Medtech #RSM

Amplitude Vascular Systems, one of our portfolio companies, has entered into a strategic agreement with the The Jacobs Institute, a medical innovation center in Buffalo, NY. This partnership will support AVS in expanding the use of its Pulse Intravascular Lithotripsy (IVL) System beyond peripheral arterial disease to include coronary and carotid indications. Congratulations to AVS and the JI on this step toward commercialization of the transformative #AVS technology! #VC #BioStar #Medtech #AVSPulse #Cardiovascular #IVL

Big news! We are excited to share that Johnson & Johnson (NYSE: JNJ) has announced it will acquire V-Wave, a BioStar portfolio company, for up to $1.7 billion! V-Wave’s transformative shunt technology has the potential to significantly help patients around the world who suffer from heart failure with reduced ejection fraction. We hope you will join us in congratulating both the J&J and V-Wave team! #VC #BioStar #Medtech #VWave #Cardiovascular #HeartFailure

With the smallest wristed instruments in the world, the possibilities are endless for Medical Microinstruments, Inc. Here’s an example of how robotics is moving across the body from breast cancer to lymphatic surgery to neurosurgery. #MMI, one of our portfolio companies, is leading the way! #VC #BioStar #Medtech #MMI #Microsurgery #Robotics